Spain May Set Further Restrictions on The Sale and Distribution of Vapes

RegulationsMarket
Jul.05.2022
The Ministry of Health is looking into banning online sales of vaping products, and limit sales to specialized tobacco shops.

The Royal Decree 579/2017, is the legislation pertaining to the manufacture, advertising and sale of vaping products in Spain. The decree basically translates the Tobacco Products Directive (TPD) into Spanish regulations, and has been effective since the 11th of June 2017.

Spain May Set Further Restrictions on The Sale and Distribution of Vapes

And now, says Euro Weekly, the Spanish Government has set out to put further restrictions on the sale and distribution of e-cigarettes, with the Ministry of Health saying that they aim to reformulate the local anti-smoking legislation and extend it to the use of e-cigarettes, as they cause “harmful short-term effects”.

 

Led by Carolina Darias, the ministry said they are concerned about the sale of the devices, as “there is a large number of websites where nicotine-based devices can be bought online, and the methods for preventing access to minors are neither sufficient nor effective.” To this effect, they are looking into banning online sales of vaping products, and limit sales to specialised tobacco shops.

 

A general e-liquid tax is proposed

 

Similarly last year, Spain’s Ministry of Finance said it wanted to tighten the tobacco regulatory framework, so as to be in line with WHO and EU TPD standards. The umbrella organisation- the National Committee for the Prevention of Smoking (Comité Nacional para la Prevención del Tabaquismo (CNPT) had prepared a report for the Ministry of Health suggesting an excise duty based on both volume of e-liquid and nicotine content.

 

The report proposed a general e-liquid tax at the EU average rate of €0.15 per ml, with an additional element for nicotine content at €0.006 per mg. The group said that with an average tax rate of 35.6%, the Spanish government could collect €35m in revenue a year from the tax. “This is a viable option for the Spanish economy,” said a CNPT spokesperson to ECigIntelligence. “The government would obtain an economic return, while at the same time promoting a reduction in the consumption of these products.”

 

Commenting on the proposed tax, ECigIntelligence has recently highlighted that if the Spanish government indeed agrees to the tax, the local vape industry would be deeply impacted. The agency believes that the CNPT’s proposal is currently being discussed internally between the Ministry of Health and the Ministry of Finance.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22